HUTCHMED (China) Limited (AIM: HCM)
London
· Delayed Price · Currency is GBP · Price in GBX
254.00
+8.00 (3.25%)
Jan 6, 2025, 8:39 AM GMT+1
HUTCHMED (China) Employees
HUTCHMED (China) had 1,988 employees as of December 31, 2023. The number of employees decreased by 37 or -1.83% compared to the previous year.
Employees
1,988
Change (1Y)
-37
Growth (1Y)
-1.83%
Revenue / Employee
245.34K GBP
Profits / Employee
-16.86K GBP
Market Cap
2.18B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
Indivior | 1,164 |
Oxford Nanopore Technologies | 1,238 |
HUTCHMED (China) News
- 4 days ago - Chinese regulators accept NDA for Orpathys/Tagrisso combo - Seeking Alpha
- 4 days ago - Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million - Benzinga
- 4 days ago - Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million - Benzinga
- 4 days ago - Hutchmed sells stake in unit - BusinessMirror
- 4 days ago - HUTCHMED divests $608 million in non-core assets - Seeking Alpha
- 5 days ago - HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer Patients with MET amplification After Progression on First-Line EGFR Inhibitor Therapy - GlobeNewsWire
- 5 days ago - Billionaire Li Ka-shing's Hutchmed in $608 mln health unit stake sales - Reuters
- 5 days ago - HUTCHMED to divest 45% stake in JV with Shanghai Pharma - Seeking Alpha